Actions of platelet-activating factor on isolated rabbit basilar artery: Modulation by activated polymorphonuclear leukocytes

Journal of Vascular Research

Volumn 32, Issue 1, 1995, Pages 49-57

  Akopov, S E ^a   Sercombe, R ^a   Seylaz, J ^a  

^a CNRS   (France)

Author keywords

Basilar artery; Endothelium; Endothelium derived relaxing factor; Platelet activating factor; Polymorphonuclear leukocytes

Indexed keywords

ACETYLCHOLINE; FORMYLPEPTIDE; INDOMETACIN; N(G) NITROARGININE; NITROPRUSSIDE SODIUM; NORDIHYDROGUAIARETIC ACID; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; CONTROLLED STUDY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANIMAL; BASILAR ARTERY; CELL ADHESION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; IN VITRO; INDOMETHACIN; NEUTROPHILS; NORDIHYDROGUAIARETIC ACID; PLATELET ACTIVATING FACTOR; RABBITS; SUPPORT, NON-U.S. GOV'T; VASCULAR RESISTANCE;

EID: 0028902175     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000159077     Document Type: Article

References (38)

1. Vandongen R: Platelet activating factor and the circulation. J Hypcrtens 1991:9:771-778.
2. Steward IG. Piper PG: Platelet-activating factor induced vasoconstriction in rat isolated perfused hearts: Contribution of cyclooxygenase and lipoxygenase arachidonie acid metabolites. Pharmacol ResCommun 1986:18:163-172.
3. Stahl G. Lefer DJ. Lefer AM: PAF-aceter induced cardiac dysfunction in the isolated perfused guinea pig hearts. Naunyn Schmiedc- bergs Arch Pharmacol 1987:336:459-463.
4. Uski TK, Rcinstrup P: Actions of platelet-activating factor on isolated feline and human cerebral arteries. J Cereb Blood Row Metab 1990:10:428-431.
5. Chiba Y, Mikoda N, Kawasaki H. Katsuaki I: Endothelium-dependent relaxant action of platelet activating factor in the rat mesenteric artery. Naunyn Schmicdcbergs Arch Pharmacol 1990:341:68-73.
6. Jin N. Packer CS. Rhoades RA: Platelet activating factor causes relaxation of isolated pulmonary artery and aorta. Adv Exp Med Biol 1991;30:517-522.
7. Moritoki H. Hisavama T. Takcuchi S. Mivano H, Kondoh W: Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta. Br J Pharmacol 1992; 107:196- 201.
8. Junkos LA. Ren YL. Arima S. Ito S: Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arterioles of the rabbit kidney. J Clin Invest 1993:91:1374-1379.
9. Ma XL, Tsao PS, Vichman GE, Lefer AM: Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow pcrfusion- reperfusion cat coronary artery. Circ Res 1991; 69:95-106.
10. Akopov SE, Grigorian MR. Gabrielian ES: The endotheliumdependent relaxation of human middle cerebral artery: Effect of activated neutrophils. Experientia 1992:48:34-36.
11. De Kimpe SJ. Van Heuven-Nolsen D, Nijkamp FP: Acetylcholincinduccd relaxation in bovine isolated mesenteric arteries is supressed by polymorphonuclear leukocytes. Br J Pharmacol 1993;109:8-13.
12. Lefer AM, Siegfried MR, Ma XL: Protection of ischemiarcperfusion injury by sydnonimine NO donors via inhibition of neutrophil-endothelium interaction. J Cardiovasc Pharmacol 1993:22(suppl 7):27-33.
13. Braquct PL. Touqui TYS. Vargaftig BB: Perspectives in platelet activating factor research. Pharmacol Rev 1987;39:97-145.
14. Milhoan KA, Lane TA, Bloor CM: Hypoxia induces endothelial cells to increase their adherence for neutrophils: Role of PAF. Am J Physiol 1992;263:H956-H962.
15. Bicnvenu K. Russel J, Granger DN: Platelet- activating factor promotes shear ratc-dcpcn- dent leukocyte adhesion in postcapillary' venules. J Lipid Mediat 1993:8:95-103.
16. Frerichs KU. Fcucrstcin GZ: Platelet-activating factor: Key mediator in neuroinjury? Cere- brovasc Brain Metab Rev 1990:2:148-160.
17. Sercombe R. Verrecchia C, Oudart N, Dimi- triadou V, Sevlaz J: Pial artery responses to norepinephrine potentiated by endothelium removal. J Cereb Blood Row Metab 1985:5:312- 317.
18. Katusic ZS, Michenfelder JD. Milde JH: Isch- emia-repcrfusion docs not affect reactivity of isolated canine basilar artery. J Cereb Blood Flow Metab 1991:11:824-828.
19. Grigoriadis G. Stewart AG: Albumin inhibits platelet-activating factor (PAF) - induced responses in platelet and macrophages: Implication for the biologically active form of PAF. Br J Pharmacol 1992;107:73-77.
20. Mugge A. Heistad DD. Padgett RC, Waack BJ, Densen P. Lopez JAG: Mechanisms of contraction induced by human leukocytes in normal and atherosclerotic arteries. Circ Res 1991:69: 871-880.
21. Vane JR. Anggard EE, Botting RM: Regulatory function of vascular endothelium. N Engl J Med 1990;323:27-36.
22. Fishman WH. Kato K. Anstiss CL. Green S: Human serum -glucuronidase: Its measurement and some of its properties. Clin Chim Acta 1967;15:435-441.
23. Ohlstein EH. Nichols AJ: Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle. Circ Res 1989:65:917-924.
24. Moncada S. Palmer RMJ. Higgs AE: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-142.
25. Bkailv G. D'Orleans-Justc P, Naik R, Perodin J, Stankova J, Abdulnour E, Rola-Pleszczynski M: PAF activation of a voltage-gated type of calcium channel in human and canine aortic endothelial cells. Br J Pharmacol 1993; 110: 519-520.
26. Vanhouttc PM: Role of calcium and endothelium in hypertension, cardiovascular disease, and subsequent vascular events. J Cardiovasc Pharmacol 1992;19 (suppl 3:6-10.)
27. Solcviev AI. Braquct P: Platelet-activating factor (PAF) induces contraction of saponin-skin- ned smooth muscle of coronary artery. Lipids 1991:26:1274-1276.
28. Ohar JA. Pyle JA, Waller KS, Hyers TM, Webster RO. Lagunoff D: A rabbit model of pulmonary hypertension induced by the synthetic platelet-activating factor acetylglyceryl ether phosphorvl-choline. Annu Rev Rcspir Dis 1990;141:104-109.
29. Sagach VZ. Zhukova AV. Braquct P: Endothelium-dependent effect of platelet-activating factor in the coronary circulation. J Cardiovasc Pharmacol 1992:20(suppl 12):85-89.
30. Mullane K: Neutrophils and endothelial changes in rcpcrfusion injury. Trends Cardiovasc Med 1991;1:282-289.
31. Sobey CG. Woodman OL: Myocardial ischcmia: What happens to the coronary arteries. Trends Pharmacol Sci 1993;14:448-453.
32. Lefer DJ. Nakanishi K, Johnston WE, Vinten-Johanse J: Antineutrophil and myocardial protecting actions of a novel nitric oxide donor alter acute myocardial ischemia and reperfusion in dogs. Circulation 1993;88:2337-2350.
33. Kim YD. Danchak RM. Heim KF. lees DE. Myers AK: Constriction of canine coronary arteries by platelet activating factor after brief ischemia. Prostaglandins 1993:46:269-276.
34. Nishida M. Kuruya T. Hoshida S, Kim Y, Kitabatake A. Kamada T, Tada M: Polymorphonuclear leukocytes induced vasoconstriction in isolated canine coronary arteries. Circ Res 1990:66:253-258.
35. Sala A. Rosson G. Buccellati C, Berti F, Folco G. Vlaclouf J: Formation of sulphidopeptide- lcukotrienes by cell-cell interaction causes coronary vaso-constriction in isolated, cell-per- fused heart of rabbit. Br J Pharmacol 1993; 110: 1206-1212.
36. Sessa WC, Mullane KM: Release of neutrophil derived vasoconstrictor agent which augments platelet-induced contraction of blood vessels in vitro. Br J Pharmacol 1990:99:553-559.
37. Whittle BJR, Moncada S: The endothelin explosion: A pathophysiological reality or a biological curiosity. Circulation 1990:81:2022- 2025.
38. Germann P, Laher I, Bevan JA: Platelets augment rabbit cerebral artery constriction by activating protein kinase C. Stroke 1991:22:1534- 1540.